Dimitris Emmanouil
Dimitris Emmanouil has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Y. Hardan
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, USA
1 shared publication - Antonios Patrikiou
Unit for Human Reproduction, 1st Department of Obstetrics & Gynaecology, Aristotle University Medical School, Papageorgiou General Hospital, 56403 Thessaloniki, Greece
1 shared publication - John W. Berkenbosch
University of Louisville, Norton Children’s Hospital
1 shared publication - Konstantinos Arapostathis
Department of Paediatric Dentistry, School of Dentistry, Aristotle University of Thessaloniki, Thessaloniki, Greece
1 shared publication - Nikolaos Dabarakis
Department of Dentoalveolar Surgery, Surgical Implantology and Radiology, School of Dentistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
1 shared publication - Nikolaos Economides
Department of Endodontology, School of Dentistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
1 shared publication
Latest Publications
- 25 August 2025
- Published by Springer Nature
- p. 499-514
Special Considerations During Sedation of the Child with Autism Spectrum Disorder
- 25 August 2025
- Published by Springer Nature
- p. 499-514
Special Considerations During Sedation of the Child with Autism Spectrum Disorder
- Open Access
- 30 September 2008
- Published by Springer Nature in BMC Oral Health
- Vol. 8 (1) , 29
Psychometric properties of Greek versions of the Modified Corah Dental Anxiety Scale (MDAS) and the Dental Fear Survey (DFS)
A growing body of literature describes the performance of dental fear questionnaires in various countries. We describe the psychometric properties of Greek versions of the Modified Dental Anxiety Scale (MDAS) and the Dental Fear Survey (DFS) in adult Greek patients.
- 30 September 2008
- Published by Springer Nature in BMC Oral Health
- Vol. 8 (1) , 29
Open AccessPsychometric properties of Greek versions of the Modified Corah Dental Anxiety Scale (MDAS) and the Dental Fear Survey (DFS)
A growing body of literature describes the performance of dental fear questionnaires in various countries. We describe the psychometric properties of Greek versions of the Modified Dental Anxiety Scale (MDAS) and the Dental Fear Survey (DFS) in adult Greek patients.
- 1 March 2007
- Published by American Dental Society of Anesthesiology (ADSA) in Anesthesia Progress
- Vol. 54 (1) , 9-18
Advances in Understanding the Actions of Nitrous Oxide
Nitrous oxide (N(2)O) has been used for well over 150 years in clinical dentistry for its analgesic and anxiolytic properties. This small and simple inorganic chemical molecule has indisputable effects of analgesia, anxiolysis, and anesthesia that are of great clinical interest. Recent studies have helped to clarify the analgesic mechanisms of N(2)O, but the mechanisms involved in its anxiolytic and anesthetic actions remain less clear. Findings to date indicate that the analgesic effect of N(2)O is opioid in nature, and, like morphine, may involve a myriad of neuromodulators in the spinal cord. The anxiolytic effect of N(2)O, on the other hand, resembles that of benzodiazepines and may be initiated at selected subunits of the gamma-aminobutyric acid type A (GABA(A)) receptor. Similarly, the anesthetic effect of N(2)O may involve actions at GABA(A) receptors and possibly at N-methyl-D-aspartate receptors as well. This article reviews the latest information on the proposed modes of action for these clinical effects of N(2)O.
- 1 March 2007
- Published by American Dental Society of Anesthesiology (ADSA) in Anesthesia Progress
- Vol. 54 (1) , 9-18
Advances in Understanding the Actions of Nitrous Oxide
Nitrous oxide (N(2)O) has been used for well over 150 years in clinical dentistry for its analgesic and anxiolytic properties. This small and simple inorganic chemical molecule has indisputable effects of analgesia, anxiolysis, and anesthesia that are of great clinical interest. Recent studies have helped to clarify the analgesic mechanisms of N(2)O, but the mechanisms involved in its anxiolytic and anesthetic actions remain less clear. Findings to date indicate that the analgesic effect of N(2)O is opioid in nature, and, like morphine, may involve a myriad of neuromodulators in the spinal cord. The anxiolytic effect of N(2)O, on the other hand, resembles that of benzodiazepines and may be initiated at selected subunits of the gamma-aminobutyric acid type A (GABA(A)) receptor. Similarly, the anesthetic effect of N(2)O may involve actions at GABA(A) receptors and possibly at N-methyl-D-aspartate receptors as well. This article reviews the latest information on the proposed modes of action for these clinical effects of N(2)O.